In recent years, there has been increased attention to exploring non-mammalian model organisms to study the antioxidant properties of bioactive compounds. These models include both unicellular organisms, such as Escherichia coli and Saccharomyces cerevisiae, and multicellular organisms, such as Caenorhabditis elegans, Drosophila melanogaster, and Danio rerio. In particular, multicellular models have emerged as promising systems due to their ease of establishing systems and maintenance, short duration of experiments, ease of genetic manipulation and genome-wide screening, availability as off-the-shelf models, safety, and cost-effectiveness. Notably, these organisms share a high degree of gene homology with humans, ranging from 65% to 84%, which positions them as powerful platforms for investigating human disease mechanisms. These advantages make them attractive candidates for investigating the potential health benefits of various bioactive compounds before resorting to mammalian models. This review delves into the rationale for utilizing these emerging non-mammalian model organisms during preliminary stages of research, emphasizing their distinct advantages over traditional mammalian models. It also highlights their significant contributions to advancing our understanding of the antioxidant mechanisms of bioactive compounds, shedding light on their potential therapeutic implications for human health. By leveraging these models, researchers can efficiently screen and validate bioactive compounds, laying a robust foundation for subsequent translational studies in mammalian systems.
Underutilized plant by-products are an overlooked source of natural extracts that contain antioxidant bioactive compounds and therapeutic potential. Oxidative stress significantly contributes to the development of various chronic diseases. In this context, natural extracts rich in bioactive compounds derived from underutilized plant by-products emerge as promising options for developing antioxidant-based therapies that target oxidative stress-related molecular pathways involved in the pathogenesis of chronic disease. The valorization of by-products through the recovery of antioxidant-rich extracts is particularly appealing, as non-edible plant parts often contain higher levels of bioactive compounds than their edible counterparts. This review provides a comprehensive overview of antioxidant natural extracts and their major bioactive components, including polyphenols (particularly flavonoids and phenolic acids), terpenoids, alkaloids, and other redox-active compounds.
15 November 2023 in Revista Brasileira de Farmacognosia
Infections caused by Escherichiacoli, Staphylococcus aureus, Salmonella Typhimurium, and Listeria monocytogenes are linked to contaminated food or water, while antibiotic resistance limits treatment options. Plant extracts are considered potential alternatives, and deep eutectic solvents and natural deep eutectic solvents (DES and NADES) offer a sustainable approach to metabolite extraction. Yucca schidigera powder was extracted using butanol (YSBE) and a NADES composed of choline chloride and lactic acid at a 1:1 molar ratio (YS-NADES). Bromatological composition, saponin content, total phenols and flavonoids, emulsifying and foaming capacities, antioxidant activity, and antibacterial properties were analyzed. YSBE contained 25.43% saponins, while YS-NADES had 0.093%. YSBE had higher protein (0.73%) and carbohydrate (77.5%) content than YS-NADES (0.03% and 0.95%, respectively). Antioxidant activity (DPPH, TEAC, ORAC) was significantly higher in YSBE than in YS-NADES. Phenol and flavonoid concentrations were also greater in YSBE. E. coli showed less sensitivity to both extracts than S. Typhimurium, S. aureus, and L. monocytogenes, while S. Typhimurium was less sensitive to YS-NADES. This study provides insights into the bromatological composition, antioxidant potential, and antibacterial properties of Y. schidigera extracted with NADES, highlighting its potential applications.
20 March 2025 in Revista Brasileira de Farmacognosia
The increasing prevalence of antibiotic-resistant Salmonella Typhimurium poses a serious public health challenge, prompting the exploration of alternative antimicrobial strategies. This study evaluated the antibacterial and antibiofilm activities of chitosan microparticles containing Yucca baccata butanolic extract (MPCY) against S. Typhimurium in vitro. The extract (YBE), rich in steroidal saponins (25.04%), was efficiently encapsulated in microparticles (84.54% immobilization efficiency). Antibacterial activity revealed a minimum inhibitory concentration (MIC) of 60 mg/mL for YBE, while MPCY exhibited a MIC of 200 mg/mL. Both treatments significantly inhibited biofilm formation at sub-MIC levels, with YBE (60 mg/mL) and MPCY (200 mg/mL) reducing biofilm biomass by 58.97% and 52.44%, respectively. However, motility inhibition remained below 6% across all treatments. In silico docking suggested that asparagoside C, the predominant saponin in YBE, may interfere with the BcsA subunit of cellulose synthase, potentially impairing biofilm synthesis by disrupting c-di-GMP signaling. Toxicity assays using Artemia salina indicated no cytotoxicity for MPCY up to 400 mg/mL, in contrast to YBE, which showed a lethal concentration 50 (LC₅₀) of 0.24 mg/mL. These findings support the potential of MPCY as a safe and effective antimicrobial system, with promising applications in food safety and pharmaceutical development. Further in vivo studies are warranted to confirm its efficacy and biosafety.